2GD4 - JenaLib

Asymmetric Unit (109, 218)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
001	UniProt	VAR_007033	I	39	N	ANT3_HUMAN	Disease (AT3D)	28929468	C/I	I	7	N
002	UniProt	VAR_007034	M	52	T	ANT3_HUMAN	Unclassified	---	C/I	M	20	T
003	UniProt	VAR_071199	C	53	F	ANT3_HUMAN	Disease (AT3D)	---	C/I	C	21	F
004	UniProt	VAR_007035	R	56	C	ANT3_HUMAN	Disease (AT3D)	28929469	C/I	R	24	C
005	UniProt	VAR_007036	P	73	L	ANT3_HUMAN	Disease (AT3D)	121909551	C/I	P	41	L
006	UniProt	VAR_075213	G	262	D	FA10_HUMAN	Unclassified (FA10D)	---	B/H	G	43	D
007	UniProt	VAR_007037	R	79	C	ANT3_HUMAN	Disease (AT3D)	121909547	C/I	R	47	C
008	UniProt	VAR_007038	R	79	H	ANT3_HUMAN	Disease (AT3D)	121909552	C/I	R	47	H
009	UniProt	VAR_007039	R	79	S	ANT3_HUMAN	Disease (AT3D)	121909547	C/I	R	47	S
010	UniProt	VAR_007041	R	89	C	ANT3_HUMAN	Disease (AT3D)	147266200	C/I	R	57	C
011	UniProt	VAR_007042	F	90	L	ANT3_HUMAN	Disease (AT3D)	---	C/I	F	58	L
012	UniProt	VAR_027452	Y	95	C	ANT3_HUMAN	Disease (AT3D)	---	C/I	Y	63	C
013	UniProt	VAR_012316	Y	95	S	ANT3_HUMAN	Disease (AT3D)	---	C/I	Y	63	S
014	UniProt	VAR_027453	L	98	P	ANT3_HUMAN	Disease (AT3D)	---	C/I	L	66	P
015	UniProt	VAR_065437	G	289	R	FA10_HUMAN	Disease (FA10D)	121964946	B/H	G	69	R
016	UniProt	VAR_007044	P	112	T	ANT3_HUMAN	Disease (AT3D)	---	C/I	P	80	T
017	UniProt	VAR_065438	E	304	K	FA10_HUMAN	Disease (FA10D)	747292771	B/H	E	84	K
018	UniProt	VAR_027454	M	121	K	ANT3_HUMAN	Disease (AT3D)	---	C/I	M	89	K
019	UniProt	VAR_071200	G	125	D	ANT3_HUMAN	Disease (AT3D)	---	C/I	G	93	D
020	UniProt	VAR_027455	C	127	R	ANT3_HUMAN	Disease (AT3D)	121909573	C/I	C	95	R
021	UniProt	VAR_007045	L	131	F	ANT3_HUMAN	Disease (AT3D)	121909567	C/I	L	99	F
022	UniProt	VAR_007046	L	131	V	ANT3_HUMAN	Disease (AT3D)	---	C/I	L	99	V
023	UniProt	VAR_007047	Q	133	K	ANT3_HUMAN	Disease (AT3D)	---	C/I	Q	101	K
024	UniProt	VAR_065434	E	142	K	FA10_HUMAN	Unclassified (FA10D)	61753266	A/L	E	102	K
025	UniProt	VAR_065439	D	322	N	FA10_HUMAN	Disease (FA10D)	121964942	B/H	D	102	N
026	UniProt	VAR_065440	R	327	W	FA10_HUMAN	Disease (FA10D)	770119164	B/H	R	107	W
027	UniProt	VAR_065435	C	149	Y	FA10_HUMAN	Disease (FA10D)	---	A/L	C	109	Y
028	UniProt	VAR_065436	C	151	Y	FA10_HUMAN	Disease (FA10D)	---	A/L	C	111	Y
029	UniProt	VAR_020176	A	152	T	FA10_HUMAN	Polymorphism	3211772	A/L	A	112	T
030	UniProt	VAR_027456	K	146	E	ANT3_HUMAN	Disease (AT3D)	---	C/I	K	114	E
031	UniProt	VAR_013085	T	147	A	ANT3_HUMAN	Polymorphism	2227606	C/I	T	115	A
032	UniProt	VAR_007049	S	148	P	ANT3_HUMAN	Disease (AT3D)	121909569	C/I	S	116	P
033	UniProt	VAR_065441	V	338	M	FA10_HUMAN	Disease (FA10D)	121964947	B/H	V	118	M
034	UniProt	VAR_007050	Q	150	P	ANT3_HUMAN	Disease (AT3D)	765445413	C/I	Q	118	P
035	UniProt	VAR_007051	H	152	Y	ANT3_HUMAN	Disease (AT3D)	---	C/I	H	120	Y
036	UniProt	VAR_007053	L	158	P	ANT3_HUMAN	Disease (AT3D)	---	C/I	L	126	P
037	UniProt	VAR_027457	C	160	Y	ANT3_HUMAN	Disease (AT3D)	---	C/I	C	128	Y
038	UniProt	VAR_065442	E	350	K	FA10_HUMAN	Disease (FA10D)	372309538	B/H	E	129	K
039	UniProt	VAR_007054	R	161	Q	ANT3_HUMAN	Disease (AT3D)	121909563	C/I	R	129	Q
040	UniProt	VAR_065443	T	358	M	FA10_HUMAN	Disease (FA10D)	768222784	B/H	T	135	M
041	UniProt	VAR_012750	N	167	T	ANT3_HUMAN	Polymorphism	121909570	C/I	N	135	T
042	UniProt	VAR_071201	S	170	P	ANT3_HUMAN	Disease (AT3D)	---	C/I	S	138	P
043	UniProt	VAR_065444	G	363	S	FA10_HUMAN	Disease (FA10D)	---	B/H	G	140	S
044	UniProt	VAR_065445	R	366	C	FA10_HUMAN	Disease (FA10D)	104894392	B/H	R	143	C
045	UniProt	VAR_027458	L	178	H	ANT3_HUMAN	Disease (AT3D)	---	C/I	L	146	H
046	UniProt	VAR_027459	F	179	L	ANT3_HUMAN	Disease (AT3D)	---	C/I	F	147	L
047	UniProt	VAR_065446	S	374	P	FA10_HUMAN	Disease (FA10D)	121964941	B/H	S	152	P
048	UniProt	VAR_007055	Y	190	C	ANT3_HUMAN	Polymorphism	---	C/I	Y	158	C
049	UniProt	VAR_072751	V	382	A	FA10_HUMAN	Disease (FA10D)	---	B/H	V	160	A
050	UniProt	VAR_065447	P	383	S	FA10_HUMAN	Disease (FA10D)	121964940	B/H	P	161	S
051	UniProt	VAR_007056	Y	198	C	ANT3_HUMAN	Disease (AT3D)	---	C/I	Y	166	C
052	UniProt	VAR_027460	Y	198	H	ANT3_HUMAN	Disease (AT3D)	---	C/I	Y	166	H
053	UniProt	VAR_065448	C	390	F	FA10_HUMAN	Disease (FA10D)	199778916	B/H	C	168	F
054	UniProt	VAR_027461	S	214	F	ANT3_HUMAN	Disease (AT3D)	---	C/I	S	182	F
055	UniProt	VAR_065449	C	404	R	FA10_HUMAN	Disease (FA10D)	---	B/H	C	182	R
056	UniProt	VAR_007057	S	214	Y	ANT3_HUMAN	Disease (AT3D)	483352854	C/I	S	182	Y
057	UniProt	VAR_065450	G	406	S	FA10_HUMAN	Disease (FA10D)	376163818	B/H	G	184	S
058	UniProt	VAR_071202	I	218	N	ANT3_HUMAN	Disease (AT3D)	---	C/I	I	186	N
059	UniProt	VAR_007059	N	219	D	ANT3_HUMAN	Disease (AT3D)	121909571	C/I	N	187	D
060	UniProt	VAR_007058	N	219	K	ANT3_HUMAN	Disease (AT3D)	---	C/I	N	187	K
061	UniProt	VAR_027463	S	223	P	ANT3_HUMAN	Disease (AT3D)	121909572	C/I	S	191	P
062	UniProt	VAR_065451	G	420	R	FA10_HUMAN	Disease (FA10D)	750759634	B/H	G	196	R
063	UniProt	VAR_072752	G	421	D	FA10_HUMAN	Disease (FA10D)	758726161	B/H	G	197	D
064	UniProt	VAR_027464	T	243	I	ANT3_HUMAN	Disease (AT3D)	---	C/I	T	211	I
065	UniProt	VAR_071203	V	248	G	ANT3_HUMAN	Disease (AT3D)	---	C/I	V	216	G
066	UniProt	VAR_027465	I	251	T	ANT3_HUMAN	Disease (AT3D)	---	C/I	I	219	T
067	UniProt	VAR_065452	K	448	N	FA10_HUMAN	Disease (FA10D)	---	B/H	K	224	N
068	UniProt	VAR_027466	W	257	R	ANT3_HUMAN	Disease (AT3D)	---	C/I	W	225	R
069	UniProt	VAR_027467	F	261	L	ANT3_HUMAN	Disease (AT3D)	---	C/I	F	229	L
070	UniProt	VAR_007060	E	269	K	ANT3_HUMAN	Disease (AT3D)	758087836	C/I	E	237	K
071	UniProt	VAR_007062	M	283	I	ANT3_HUMAN	Disease (AT3D)	---	C/I	M	251	I
072	UniProt	VAR_027468	M	283	V	ANT3_HUMAN	Disease (AT3D)	---	C/I	M	251	V
073	UniProt	VAR_071204	R	293	P	ANT3_HUMAN	Disease (AT3D)	---	C/I	R	261	P
074	UniProt	VAR_007063	L	302	P	ANT3_HUMAN	Disease (AT3D)	---	C/I	L	270	P
075	UniProt	VAR_007064	I	316	N	ANT3_HUMAN	Disease (AT3D)	---	C/I	I	284	N
076	UniProt	VAR_027469	S	323	P	ANT3_HUMAN	Disease (AT3D)	---	C/I	S	291	P
077	UniProt	VAR_007065	E	334	K	ANT3_HUMAN	Disease (AT3D)	---	C/I	E	302	K
078	UniProt	VAR_007067	S	381	P	ANT3_HUMAN	Disease (AT3D)	121909565	C/I	S	349	P
079	UniProt	VAR_007068	R	391	Q	ANT3_HUMAN	Polymorphism	201541724	C/I	R	359	Q
080	UniProt	VAR_027470	S	397	P	ANT3_HUMAN	Disease (AT3D)	---	C/I	S	365	P
081	UniProt	VAR_027471	D	398	H	ANT3_HUMAN	Disease (AT3D)	---	C/I	D	366	H
082	UniProt	VAR_071205	H	401	R	ANT3_HUMAN	Disease (AT3D)	---	C/I	H	369	R
083	UniProt	VAR_027472	S	412	R	ANT3_HUMAN	Disease (AT3D)	---	C/I	S	380	R
084	UniProt	VAR_007069	A	414	T	ANT3_HUMAN	Disease (AT3D)	121909557	C/I	A	382	T
085	UniProt	VAR_007070	A	416	P	ANT3_HUMAN	Disease (AT3D)	28930978	C/I	A	384	P
086	UniProt	VAR_007071	A	416	S	ANT3_HUMAN	Disease (AT3D)	121909548	C/I	A	384	S
087	UniProt	VAR_007072	A	419	V	ANT3_HUMAN	Disease (AT3D)	121909568	C/I	A	387	V
088	UniProt	VAR_007073	G	424	D	ANT3_HUMAN	Disease (AT3D)	121909566	C/I	G	392	D
089	UniProt	VAR_007075	R	425	C	ANT3_HUMAN	Disease (AT3D)	121909554	C/I	R	393	C
090	UniProt	VAR_007074	R	425	H	ANT3_HUMAN	Disease (AT3D)	121909549	C/I	R	393	H
091	UniProt	VAR_007076	R	425	P	ANT3_HUMAN	Disease (AT3D)	121909549	C/I	R	393	P
092	UniProt	VAR_007077	S	426	L	ANT3_HUMAN	Disease (AT3D)	121909550	C/I	S	394	L
093	UniProt	VAR_007078	F	434	C	ANT3_HUMAN	Disease (AT3D)	---	C/I	F	402	C
094	UniProt	VAR_007080	F	434	L	ANT3_HUMAN	Disease (AT3D)	---	C/I	F	402	L
095	UniProt	VAR_007079	F	434	S	ANT3_HUMAN	Disease (AT3D)	---	C/I	F	402	S
096	UniProt	VAR_007081	A	436	T	ANT3_HUMAN	Disease (AT3D)	121909546	C/I	A	404	T
097	UniProt	VAR_007082	N	437	K	ANT3_HUMAN	Disease (AT3D)	---	C/I	N	405	K
098	UniProt	VAR_009258	R	438	G	ANT3_HUMAN	Disease (AT3D)	---	C/I	R	406	G
099	UniProt	VAR_007083	R	438	M	ANT3_HUMAN	Disease (AT3D)	---	C/I	R	406	M
100	UniProt	VAR_071206	P	439	A	ANT3_HUMAN	Disease (AT3D)	---	C/I	P	407	A
101	UniProt	VAR_007084	P	439	L	ANT3_HUMAN	Disease (AT3D)	121909555	C/I	P	407	L
102	UniProt	VAR_007085	P	439	T	ANT3_HUMAN	Disease (AT3D)	---	C/I	P	407	T
103	UniProt	VAR_027473	L	441	P	ANT3_HUMAN	Disease (AT3D)	---	C/I	L	409	P
104	UniProt	VAR_007086	I	453	T	ANT3_HUMAN	Disease (AT3D)	---	C/I	I	421	T
105	UniProt	VAR_007087	G	456	R	ANT3_HUMAN	Disease (AT3D)	---	C/I	G	424	R
106	UniProt	VAR_007088	R	457	T	ANT3_HUMAN	Disease (AT3D)	---	C/I	R	425	T
107	UniProt	VAR_007090	A	459	D	ANT3_HUMAN	Disease (AT3D)	---	C/I	A	427	D
108	UniProt	VAR_007091	P	461	L	ANT3_HUMAN	Disease (AT3D)	121909564	C/I	P	429	L
109	UniProt	VAR_007092	C	462	F	ANT3_HUMAN	Disease (AT3D)	---	C/I	C	430	F

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 1 (109, 109)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
001	UniProt	VAR_007033	I	39	N	ANT3_HUMAN	Disease (AT3D)	28929468	I	I	7	N
002	UniProt	VAR_007034	M	52	T	ANT3_HUMAN	Unclassified	---	I	M	20	T
003	UniProt	VAR_071199	C	53	F	ANT3_HUMAN	Disease (AT3D)	---	I	C	21	F
004	UniProt	VAR_007035	R	56	C	ANT3_HUMAN	Disease (AT3D)	28929469	I	R	24	C
005	UniProt	VAR_007036	P	73	L	ANT3_HUMAN	Disease (AT3D)	121909551	I	P	41	L
006	UniProt	VAR_075213	G	262	D	FA10_HUMAN	Unclassified (FA10D)	---	H	G	43	D
007	UniProt	VAR_007037	R	79	C	ANT3_HUMAN	Disease (AT3D)	121909547	I	R	47	C
008	UniProt	VAR_007038	R	79	H	ANT3_HUMAN	Disease (AT3D)	121909552	I	R	47	H
009	UniProt	VAR_007039	R	79	S	ANT3_HUMAN	Disease (AT3D)	121909547	I	R	47	S
010	UniProt	VAR_007041	R	89	C	ANT3_HUMAN	Disease (AT3D)	147266200	I	R	57	C
011	UniProt	VAR_007042	F	90	L	ANT3_HUMAN	Disease (AT3D)	---	I	F	58	L
012	UniProt	VAR_027452	Y	95	C	ANT3_HUMAN	Disease (AT3D)	---	I	Y	63	C
013	UniProt	VAR_012316	Y	95	S	ANT3_HUMAN	Disease (AT3D)	---	I	Y	63	S
014	UniProt	VAR_027453	L	98	P	ANT3_HUMAN	Disease (AT3D)	---	I	L	66	P
015	UniProt	VAR_065437	G	289	R	FA10_HUMAN	Disease (FA10D)	121964946	H	G	69	R
016	UniProt	VAR_007044	P	112	T	ANT3_HUMAN	Disease (AT3D)	---	I	P	80	T
017	UniProt	VAR_065438	E	304	K	FA10_HUMAN	Disease (FA10D)	747292771	H	E	84	K
018	UniProt	VAR_027454	M	121	K	ANT3_HUMAN	Disease (AT3D)	---	I	M	89	K
019	UniProt	VAR_071200	G	125	D	ANT3_HUMAN	Disease (AT3D)	---	I	G	93	D
020	UniProt	VAR_027455	C	127	R	ANT3_HUMAN	Disease (AT3D)	121909573	I	C	95	R
021	UniProt	VAR_007045	L	131	F	ANT3_HUMAN	Disease (AT3D)	121909567	I	L	99	F
022	UniProt	VAR_007046	L	131	V	ANT3_HUMAN	Disease (AT3D)	---	I	L	99	V
023	UniProt	VAR_007047	Q	133	K	ANT3_HUMAN	Disease (AT3D)	---	I	Q	101	K
024	UniProt	VAR_065434	E	142	K	FA10_HUMAN	Unclassified (FA10D)	61753266	L	E	102	K
025	UniProt	VAR_065439	D	322	N	FA10_HUMAN	Disease (FA10D)	121964942	H	D	102	N
026	UniProt	VAR_065440	R	327	W	FA10_HUMAN	Disease (FA10D)	770119164	H	R	107	W
027	UniProt	VAR_065435	C	149	Y	FA10_HUMAN	Disease (FA10D)	---	L	C	109	Y
028	UniProt	VAR_065436	C	151	Y	FA10_HUMAN	Disease (FA10D)	---	L	C	111	Y
029	UniProt	VAR_020176	A	152	T	FA10_HUMAN	Polymorphism	3211772	L	A	112	T
030	UniProt	VAR_027456	K	146	E	ANT3_HUMAN	Disease (AT3D)	---	I	K	114	E
031	UniProt	VAR_013085	T	147	A	ANT3_HUMAN	Polymorphism	2227606	I	T	115	A
032	UniProt	VAR_007049	S	148	P	ANT3_HUMAN	Disease (AT3D)	121909569	I	S	116	P
033	UniProt	VAR_065441	V	338	M	FA10_HUMAN	Disease (FA10D)	121964947	H	V	118	M
034	UniProt	VAR_007050	Q	150	P	ANT3_HUMAN	Disease (AT3D)	765445413	I	Q	118	P
035	UniProt	VAR_007051	H	152	Y	ANT3_HUMAN	Disease (AT3D)	---	I	H	120	Y
036	UniProt	VAR_007053	L	158	P	ANT3_HUMAN	Disease (AT3D)	---	I	L	126	P
037	UniProt	VAR_027457	C	160	Y	ANT3_HUMAN	Disease (AT3D)	---	I	C	128	Y
038	UniProt	VAR_065442	E	350	K	FA10_HUMAN	Disease (FA10D)	372309538	H	E	129	K
039	UniProt	VAR_007054	R	161	Q	ANT3_HUMAN	Disease (AT3D)	121909563	I	R	129	Q
040	UniProt	VAR_065443	T	358	M	FA10_HUMAN	Disease (FA10D)	768222784	H	T	135	M
041	UniProt	VAR_012750	N	167	T	ANT3_HUMAN	Polymorphism	121909570	I	N	135	T
042	UniProt	VAR_071201	S	170	P	ANT3_HUMAN	Disease (AT3D)	---	I	S	138	P
043	UniProt	VAR_065444	G	363	S	FA10_HUMAN	Disease (FA10D)	---	H	G	140	S
044	UniProt	VAR_065445	R	366	C	FA10_HUMAN	Disease (FA10D)	104894392	H	R	143	C
045	UniProt	VAR_027458	L	178	H	ANT3_HUMAN	Disease (AT3D)	---	I	L	146	H
046	UniProt	VAR_027459	F	179	L	ANT3_HUMAN	Disease (AT3D)	---	I	F	147	L
047	UniProt	VAR_065446	S	374	P	FA10_HUMAN	Disease (FA10D)	121964941	H	S	152	P
048	UniProt	VAR_007055	Y	190	C	ANT3_HUMAN	Polymorphism	---	I	Y	158	C
049	UniProt	VAR_072751	V	382	A	FA10_HUMAN	Disease (FA10D)	---	H	V	160	A
050	UniProt	VAR_065447	P	383	S	FA10_HUMAN	Disease (FA10D)	121964940	H	P	161	S
051	UniProt	VAR_007056	Y	198	C	ANT3_HUMAN	Disease (AT3D)	---	I	Y	166	C
052	UniProt	VAR_027460	Y	198	H	ANT3_HUMAN	Disease (AT3D)	---	I	Y	166	H
053	UniProt	VAR_065448	C	390	F	FA10_HUMAN	Disease (FA10D)	199778916	H	C	168	F
054	UniProt	VAR_027461	S	214	F	ANT3_HUMAN	Disease (AT3D)	---	I	S	182	F
055	UniProt	VAR_065449	C	404	R	FA10_HUMAN	Disease (FA10D)	---	H	C	182	R
056	UniProt	VAR_007057	S	214	Y	ANT3_HUMAN	Disease (AT3D)	483352854	I	S	182	Y
057	UniProt	VAR_065450	G	406	S	FA10_HUMAN	Disease (FA10D)	376163818	H	G	184	S
058	UniProt	VAR_071202	I	218	N	ANT3_HUMAN	Disease (AT3D)	---	I	I	186	N
059	UniProt	VAR_007059	N	219	D	ANT3_HUMAN	Disease (AT3D)	121909571	I	N	187	D
060	UniProt	VAR_007058	N	219	K	ANT3_HUMAN	Disease (AT3D)	---	I	N	187	K
061	UniProt	VAR_027463	S	223	P	ANT3_HUMAN	Disease (AT3D)	121909572	I	S	191	P
062	UniProt	VAR_065451	G	420	R	FA10_HUMAN	Disease (FA10D)	750759634	H	G	196	R
063	UniProt	VAR_072752	G	421	D	FA10_HUMAN	Disease (FA10D)	758726161	H	G	197	D
064	UniProt	VAR_027464	T	243	I	ANT3_HUMAN	Disease (AT3D)	---	I	T	211	I
065	UniProt	VAR_071203	V	248	G	ANT3_HUMAN	Disease (AT3D)	---	I	V	216	G
066	UniProt	VAR_027465	I	251	T	ANT3_HUMAN	Disease (AT3D)	---	I	I	219	T
067	UniProt	VAR_065452	K	448	N	FA10_HUMAN	Disease (FA10D)	---	H	K	224	N
068	UniProt	VAR_027466	W	257	R	ANT3_HUMAN	Disease (AT3D)	---	I	W	225	R
069	UniProt	VAR_027467	F	261	L	ANT3_HUMAN	Disease (AT3D)	---	I	F	229	L
070	UniProt	VAR_007060	E	269	K	ANT3_HUMAN	Disease (AT3D)	758087836	I	E	237	K
071	UniProt	VAR_007062	M	283	I	ANT3_HUMAN	Disease (AT3D)	---	I	M	251	I
072	UniProt	VAR_027468	M	283	V	ANT3_HUMAN	Disease (AT3D)	---	I	M	251	V
073	UniProt	VAR_071204	R	293	P	ANT3_HUMAN	Disease (AT3D)	---	I	R	261	P
074	UniProt	VAR_007063	L	302	P	ANT3_HUMAN	Disease (AT3D)	---	I	L	270	P
075	UniProt	VAR_007064	I	316	N	ANT3_HUMAN	Disease (AT3D)	---	I	I	284	N
076	UniProt	VAR_027469	S	323	P	ANT3_HUMAN	Disease (AT3D)	---	I	S	291	P
077	UniProt	VAR_007065	E	334	K	ANT3_HUMAN	Disease (AT3D)	---	I	E	302	K
078	UniProt	VAR_007067	S	381	P	ANT3_HUMAN	Disease (AT3D)	121909565	I	S	349	P
079	UniProt	VAR_007068	R	391	Q	ANT3_HUMAN	Polymorphism	201541724	I	R	359	Q
080	UniProt	VAR_027470	S	397	P	ANT3_HUMAN	Disease (AT3D)	---	I	S	365	P
081	UniProt	VAR_027471	D	398	H	ANT3_HUMAN	Disease (AT3D)	---	I	D	366	H
082	UniProt	VAR_071205	H	401	R	ANT3_HUMAN	Disease (AT3D)	---	I	H	369	R
083	UniProt	VAR_027472	S	412	R	ANT3_HUMAN	Disease (AT3D)	---	I	S	380	R
084	UniProt	VAR_007069	A	414	T	ANT3_HUMAN	Disease (AT3D)	121909557	I	A	382	T
085	UniProt	VAR_007070	A	416	P	ANT3_HUMAN	Disease (AT3D)	28930978	I	A	384	P
086	UniProt	VAR_007071	A	416	S	ANT3_HUMAN	Disease (AT3D)	121909548	I	A	384	S
087	UniProt	VAR_007072	A	419	V	ANT3_HUMAN	Disease (AT3D)	121909568	I	A	387	V
088	UniProt	VAR_007073	G	424	D	ANT3_HUMAN	Disease (AT3D)	121909566	I	G	392	D
089	UniProt	VAR_007075	R	425	C	ANT3_HUMAN	Disease (AT3D)	121909554	I	R	393	C
090	UniProt	VAR_007074	R	425	H	ANT3_HUMAN	Disease (AT3D)	121909549	I	R	393	H
091	UniProt	VAR_007076	R	425	P	ANT3_HUMAN	Disease (AT3D)	121909549	I	R	393	P
092	UniProt	VAR_007077	S	426	L	ANT3_HUMAN	Disease (AT3D)	121909550	I	S	394	L
093	UniProt	VAR_007078	F	434	C	ANT3_HUMAN	Disease (AT3D)	---	I	F	402	C
094	UniProt	VAR_007080	F	434	L	ANT3_HUMAN	Disease (AT3D)	---	I	F	402	L
095	UniProt	VAR_007079	F	434	S	ANT3_HUMAN	Disease (AT3D)	---	I	F	402	S
096	UniProt	VAR_007081	A	436	T	ANT3_HUMAN	Disease (AT3D)	121909546	I	A	404	T
097	UniProt	VAR_007082	N	437	K	ANT3_HUMAN	Disease (AT3D)	---	I	N	405	K
098	UniProt	VAR_009258	R	438	G	ANT3_HUMAN	Disease (AT3D)	---	I	R	406	G
099	UniProt	VAR_007083	R	438	M	ANT3_HUMAN	Disease (AT3D)	---	I	R	406	M
100	UniProt	VAR_071206	P	439	A	ANT3_HUMAN	Disease (AT3D)	---	I	P	407	A
101	UniProt	VAR_007084	P	439	L	ANT3_HUMAN	Disease (AT3D)	121909555	I	P	407	L
102	UniProt	VAR_007085	P	439	T	ANT3_HUMAN	Disease (AT3D)	---	I	P	407	T
103	UniProt	VAR_027473	L	441	P	ANT3_HUMAN	Disease (AT3D)	---	I	L	409	P
104	UniProt	VAR_007086	I	453	T	ANT3_HUMAN	Disease (AT3D)	---	I	I	421	T
105	UniProt	VAR_007087	G	456	R	ANT3_HUMAN	Disease (AT3D)	---	I	G	424	R
106	UniProt	VAR_007088	R	457	T	ANT3_HUMAN	Disease (AT3D)	---	I	R	425	T
107	UniProt	VAR_007090	A	459	D	ANT3_HUMAN	Disease (AT3D)	---	I	A	427	D
108	UniProt	VAR_007091	P	461	L	ANT3_HUMAN	Disease (AT3D)	121909564	I	P	429	L
109	UniProt	VAR_007092	C	462	F	ANT3_HUMAN	Disease (AT3D)	---	I	C	430	F

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 2 (109, 109)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
001	UniProt	VAR_007033	I	39	N	ANT3_HUMAN	Disease (AT3D)	28929468	C	I	7	N
002	UniProt	VAR_007034	M	52	T	ANT3_HUMAN	Unclassified	---	C	M	20	T
003	UniProt	VAR_071199	C	53	F	ANT3_HUMAN	Disease (AT3D)	---	C	C	21	F
004	UniProt	VAR_007035	R	56	C	ANT3_HUMAN	Disease (AT3D)	28929469	C	R	24	C
005	UniProt	VAR_007036	P	73	L	ANT3_HUMAN	Disease (AT3D)	121909551	C	P	41	L
006	UniProt	VAR_075213	G	262	D	FA10_HUMAN	Unclassified (FA10D)	---	B	G	43	D
007	UniProt	VAR_007037	R	79	C	ANT3_HUMAN	Disease (AT3D)	121909547	C	R	47	C
008	UniProt	VAR_007038	R	79	H	ANT3_HUMAN	Disease (AT3D)	121909552	C	R	47	H
009	UniProt	VAR_007039	R	79	S	ANT3_HUMAN	Disease (AT3D)	121909547	C	R	47	S
010	UniProt	VAR_007041	R	89	C	ANT3_HUMAN	Disease (AT3D)	147266200	C	R	57	C
011	UniProt	VAR_007042	F	90	L	ANT3_HUMAN	Disease (AT3D)	---	C	F	58	L
012	UniProt	VAR_027452	Y	95	C	ANT3_HUMAN	Disease (AT3D)	---	C	Y	63	C
013	UniProt	VAR_012316	Y	95	S	ANT3_HUMAN	Disease (AT3D)	---	C	Y	63	S
014	UniProt	VAR_027453	L	98	P	ANT3_HUMAN	Disease (AT3D)	---	C	L	66	P
015	UniProt	VAR_065437	G	289	R	FA10_HUMAN	Disease (FA10D)	121964946	B	G	69	R
016	UniProt	VAR_007044	P	112	T	ANT3_HUMAN	Disease (AT3D)	---	C	P	80	T
017	UniProt	VAR_065438	E	304	K	FA10_HUMAN	Disease (FA10D)	747292771	B	E	84	K
018	UniProt	VAR_027454	M	121	K	ANT3_HUMAN	Disease (AT3D)	---	C	M	89	K
019	UniProt	VAR_071200	G	125	D	ANT3_HUMAN	Disease (AT3D)	---	C	G	93	D
020	UniProt	VAR_027455	C	127	R	ANT3_HUMAN	Disease (AT3D)	121909573	C	C	95	R
021	UniProt	VAR_007045	L	131	F	ANT3_HUMAN	Disease (AT3D)	121909567	C	L	99	F
022	UniProt	VAR_007046	L	131	V	ANT3_HUMAN	Disease (AT3D)	---	C	L	99	V
023	UniProt	VAR_007047	Q	133	K	ANT3_HUMAN	Disease (AT3D)	---	C	Q	101	K
024	UniProt	VAR_065434	E	142	K	FA10_HUMAN	Unclassified (FA10D)	61753266	A	E	102	K
025	UniProt	VAR_065439	D	322	N	FA10_HUMAN	Disease (FA10D)	121964942	B	D	102	N
026	UniProt	VAR_065440	R	327	W	FA10_HUMAN	Disease (FA10D)	770119164	B	R	107	W
027	UniProt	VAR_065435	C	149	Y	FA10_HUMAN	Disease (FA10D)	---	A	C	109	Y
028	UniProt	VAR_065436	C	151	Y	FA10_HUMAN	Disease (FA10D)	---	A	C	111	Y
029	UniProt	VAR_020176	A	152	T	FA10_HUMAN	Polymorphism	3211772	A	A	112	T
030	UniProt	VAR_027456	K	146	E	ANT3_HUMAN	Disease (AT3D)	---	C	K	114	E
031	UniProt	VAR_013085	T	147	A	ANT3_HUMAN	Polymorphism	2227606	C	T	115	A
032	UniProt	VAR_007049	S	148	P	ANT3_HUMAN	Disease (AT3D)	121909569	C	S	116	P
033	UniProt	VAR_065441	V	338	M	FA10_HUMAN	Disease (FA10D)	121964947	B	V	118	M
034	UniProt	VAR_007050	Q	150	P	ANT3_HUMAN	Disease (AT3D)	765445413	C	Q	118	P
035	UniProt	VAR_007051	H	152	Y	ANT3_HUMAN	Disease (AT3D)	---	C	H	120	Y
036	UniProt	VAR_007053	L	158	P	ANT3_HUMAN	Disease (AT3D)	---	C	L	126	P
037	UniProt	VAR_027457	C	160	Y	ANT3_HUMAN	Disease (AT3D)	---	C	C	128	Y
038	UniProt	VAR_065442	E	350	K	FA10_HUMAN	Disease (FA10D)	372309538	B	E	129	K
039	UniProt	VAR_007054	R	161	Q	ANT3_HUMAN	Disease (AT3D)	121909563	C	R	129	Q
040	UniProt	VAR_065443	T	358	M	FA10_HUMAN	Disease (FA10D)	768222784	B	T	135	M
041	UniProt	VAR_012750	N	167	T	ANT3_HUMAN	Polymorphism	121909570	C	N	135	T
042	UniProt	VAR_071201	S	170	P	ANT3_HUMAN	Disease (AT3D)	---	C	S	138	P
043	UniProt	VAR_065444	G	363	S	FA10_HUMAN	Disease (FA10D)	---	B	G	140	S
044	UniProt	VAR_065445	R	366	C	FA10_HUMAN	Disease (FA10D)	104894392	B	R	143	C
045	UniProt	VAR_027458	L	178	H	ANT3_HUMAN	Disease (AT3D)	---	C	L	146	H
046	UniProt	VAR_027459	F	179	L	ANT3_HUMAN	Disease (AT3D)	---	C	F	147	L
047	UniProt	VAR_065446	S	374	P	FA10_HUMAN	Disease (FA10D)	121964941	B	S	152	P
048	UniProt	VAR_007055	Y	190	C	ANT3_HUMAN	Polymorphism	---	C	Y	158	C
049	UniProt	VAR_072751	V	382	A	FA10_HUMAN	Disease (FA10D)	---	B	V	160	A
050	UniProt	VAR_065447	P	383	S	FA10_HUMAN	Disease (FA10D)	121964940	B	P	161	S
051	UniProt	VAR_007056	Y	198	C	ANT3_HUMAN	Disease (AT3D)	---	C	Y	166	C
052	UniProt	VAR_027460	Y	198	H	ANT3_HUMAN	Disease (AT3D)	---	C	Y	166	H
053	UniProt	VAR_065448	C	390	F	FA10_HUMAN	Disease (FA10D)	199778916	B	C	168	F
054	UniProt	VAR_027461	S	214	F	ANT3_HUMAN	Disease (AT3D)	---	C	S	182	F
055	UniProt	VAR_065449	C	404	R	FA10_HUMAN	Disease (FA10D)	---	B	C	182	R
056	UniProt	VAR_007057	S	214	Y	ANT3_HUMAN	Disease (AT3D)	483352854	C	S	182	Y
057	UniProt	VAR_065450	G	406	S	FA10_HUMAN	Disease (FA10D)	376163818	B	G	184	S
058	UniProt	VAR_071202	I	218	N	ANT3_HUMAN	Disease (AT3D)	---	C	I	186	N
059	UniProt	VAR_007059	N	219	D	ANT3_HUMAN	Disease (AT3D)	121909571	C	N	187	D
060	UniProt	VAR_007058	N	219	K	ANT3_HUMAN	Disease (AT3D)	---	C	N	187	K
061	UniProt	VAR_027463	S	223	P	ANT3_HUMAN	Disease (AT3D)	121909572	C	S	191	P
062	UniProt	VAR_065451	G	420	R	FA10_HUMAN	Disease (FA10D)	750759634	B	G	196	R
063	UniProt	VAR_072752	G	421	D	FA10_HUMAN	Disease (FA10D)	758726161	B	G	197	D
064	UniProt	VAR_027464	T	243	I	ANT3_HUMAN	Disease (AT3D)	---	C	T	211	I
065	UniProt	VAR_071203	V	248	G	ANT3_HUMAN	Disease (AT3D)	---	C	V	216	G
066	UniProt	VAR_027465	I	251	T	ANT3_HUMAN	Disease (AT3D)	---	C	I	219	T
067	UniProt	VAR_065452	K	448	N	FA10_HUMAN	Disease (FA10D)	---	B	K	224	N
068	UniProt	VAR_027466	W	257	R	ANT3_HUMAN	Disease (AT3D)	---	C	W	225	R
069	UniProt	VAR_027467	F	261	L	ANT3_HUMAN	Disease (AT3D)	---	C	F	229	L
070	UniProt	VAR_007060	E	269	K	ANT3_HUMAN	Disease (AT3D)	758087836	C	E	237	K
071	UniProt	VAR_007062	M	283	I	ANT3_HUMAN	Disease (AT3D)	---	C	M	251	I
072	UniProt	VAR_027468	M	283	V	ANT3_HUMAN	Disease (AT3D)	---	C	M	251	V
073	UniProt	VAR_071204	R	293	P	ANT3_HUMAN	Disease (AT3D)	---	C	R	261	P
074	UniProt	VAR_007063	L	302	P	ANT3_HUMAN	Disease (AT3D)	---	C	L	270	P
075	UniProt	VAR_007064	I	316	N	ANT3_HUMAN	Disease (AT3D)	---	C	I	284	N
076	UniProt	VAR_027469	S	323	P	ANT3_HUMAN	Disease (AT3D)	---	C	S	291	P
077	UniProt	VAR_007065	E	334	K	ANT3_HUMAN	Disease (AT3D)	---	C	E	302	K
078	UniProt	VAR_007067	S	381	P	ANT3_HUMAN	Disease (AT3D)	121909565	C	S	349	P
079	UniProt	VAR_007068	R	391	Q	ANT3_HUMAN	Polymorphism	201541724	C	R	359	Q
080	UniProt	VAR_027470	S	397	P	ANT3_HUMAN	Disease (AT3D)	---	C	S	365	P
081	UniProt	VAR_027471	D	398	H	ANT3_HUMAN	Disease (AT3D)	---	C	D	366	H
082	UniProt	VAR_071205	H	401	R	ANT3_HUMAN	Disease (AT3D)	---	C	H	369	R
083	UniProt	VAR_027472	S	412	R	ANT3_HUMAN	Disease (AT3D)	---	C	S	380	R
084	UniProt	VAR_007069	A	414	T	ANT3_HUMAN	Disease (AT3D)	121909557	C	A	382	T
085	UniProt	VAR_007070	A	416	P	ANT3_HUMAN	Disease (AT3D)	28930978	C	A	384	P
086	UniProt	VAR_007071	A	416	S	ANT3_HUMAN	Disease (AT3D)	121909548	C	A	384	S
087	UniProt	VAR_007072	A	419	V	ANT3_HUMAN	Disease (AT3D)	121909568	C	A	387	V
088	UniProt	VAR_007073	G	424	D	ANT3_HUMAN	Disease (AT3D)	121909566	C	G	392	D
089	UniProt	VAR_007075	R	425	C	ANT3_HUMAN	Disease (AT3D)	121909554	C	R	393	C
090	UniProt	VAR_007074	R	425	H	ANT3_HUMAN	Disease (AT3D)	121909549	C	R	393	H
091	UniProt	VAR_007076	R	425	P	ANT3_HUMAN	Disease (AT3D)	121909549	C	R	393	P
092	UniProt	VAR_007077	S	426	L	ANT3_HUMAN	Disease (AT3D)	121909550	C	S	394	L
093	UniProt	VAR_007078	F	434	C	ANT3_HUMAN	Disease (AT3D)	---	C	F	402	C
094	UniProt	VAR_007080	F	434	L	ANT3_HUMAN	Disease (AT3D)	---	C	F	402	L
095	UniProt	VAR_007079	F	434	S	ANT3_HUMAN	Disease (AT3D)	---	C	F	402	S
096	UniProt	VAR_007081	A	436	T	ANT3_HUMAN	Disease (AT3D)	121909546	C	A	404	T
097	UniProt	VAR_007082	N	437	K	ANT3_HUMAN	Disease (AT3D)	---	C	N	405	K
098	UniProt	VAR_009258	R	438	G	ANT3_HUMAN	Disease (AT3D)	---	C	R	406	G
099	UniProt	VAR_007083	R	438	M	ANT3_HUMAN	Disease (AT3D)	---	C	R	406	M
100	UniProt	VAR_071206	P	439	A	ANT3_HUMAN	Disease (AT3D)	---	C	P	407	A
101	UniProt	VAR_007084	P	439	L	ANT3_HUMAN	Disease (AT3D)	121909555	C	P	407	L
102	UniProt	VAR_007085	P	439	T	ANT3_HUMAN	Disease (AT3D)	---	C	P	407	T
103	UniProt	VAR_027473	L	441	P	ANT3_HUMAN	Disease (AT3D)	---	C	L	409	P
104	UniProt	VAR_007086	I	453	T	ANT3_HUMAN	Disease (AT3D)	---	C	I	421	T
105	UniProt	VAR_007087	G	456	R	ANT3_HUMAN	Disease (AT3D)	---	C	G	424	R
106	UniProt	VAR_007088	R	457	T	ANT3_HUMAN	Disease (AT3D)	---	C	R	425	T
107	UniProt	VAR_007090	A	459	D	ANT3_HUMAN	Disease (AT3D)	---	C	A	427	D
108	UniProt	VAR_007091	P	461	L	ANT3_HUMAN	Disease (AT3D)	121909564	C	P	429	L
109	UniProt	VAR_007092	C	462	F	ANT3_HUMAN	Disease (AT3D)	---	C	C	430	F

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

PROSITE Motifs (5, 10)

Exons (10, 22)

Sequences/Alignments

Asymmetric Unit

Reformat:	Number of residues per line = ('0' or empty: single-line sequence representation)
	Number of residues per labelling interval =
	UniProt sequence: complete aligned part

Show mapping:	SCOP domains	CATH domains	Pfam domains	Secondary structure (by author)
	SAPs(SNPs)	PROSITE motifs	Exons
	(details for a mapped element are shown in a popup box when the mouse pointer rests over it)

Chain A from PDB  Type:PROTEIN  Length:52
 aligned with FA10_HUMAN | P00742 from UniProtKB/Swiss-Prot  Length:488

    Alignment length:52
                                   136       146       156       166       176  
          FA10_HUMAN    127 KLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLE  178
               SCOP domains d2gd4a1 A:87-138 Factor X, N-terminal module         SCOP domains
               CATH domains 2gd4A00 A:87-138 Laminin                             CATH domains
               Pfam domains ---------------------------------------------------- Pfam domains
         Sec.struct. author ....hhhhhh..ee........ee....eee......eee............ Sec.struct. author
                 SAPs(SNPs) ---------------K------Y-YT-------------------------- SAPs(SNPs)
                PROSITE (1) ----------------------EGF_2           -------------- PROSITE (1)
                PROSITE (2) ---------------------------------------------------- PROSITE (2)
           Transcript 2 (1) Exon 2.6c  PDB: A:87-128 UniProt: 124-168 ---------- Transcript 2 (1)
           Transcript 2 (2) -----------------------------------------Exon 2.7a   Transcript 2 (2)
                2gd4 A   87 KLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLE  138
                                    96       106       116       126       136

Chain B from PDB  Type:PROTEIN  Length:239
 aligned with FA10_HUMAN | P00742 from UniProtKB/Swiss-Prot  Length:488

    Alignment length:239
                                   244       254       264       274       284       294       304       314       324       334       344       354       364       374       384       394       404       414       424       434       444       454       464         
          FA10_HUMAN    235 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPK  473
               SCOP domains d2gd4b1 B:16-249 Coagulation factor Xa, protease domain                                                                                                                                                                                         SCOP domains
               CATH domains 2gd4B01     2gd4B02 B:28-120,B:233-249 Trypsin-like serine proteases                                      2gd4B01 B:16-27,B:121-232 Trypsin-like serine proteases                                                             2gd4B02           CATH domains
               Pfam domains ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ..............eeeeee....eeeeee.....eeee..........eeeee............eee.eeeeee.............eeeee................hhhhhhhhh....eeeeee..............eeeeeeeehhhhhhhhh.........ee................eeeee....eeeeeee............eeeee...hhhhhhhhh....... Sec.struct. author
                 SAPs(SNPs) ---------------------------D--------------------------R--------------K-----------------N----W----------M-----------K-------M----S--C-------P-------AS------F-------------R-S-------------RD--------------------------N------------------------- SAPs(SNPs)
                PROSITE (1) TRYPSIN_DOM  PDB: B:16-243 UniProt: 235-467                                                                                                                                                                                              ------ PROSITE (1)
                PROSITE (2) -------------------------------------TRYPSI---------------------------------------------------------------------------------------------------------------------------------------TRYPSIN_SER ------------------------------------------------- PROSITE (2)
           Transcript 2 (1) ---------------Exon 2.8e  PDB: B:31-69 UniProt: 250-289---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Transcript 2 (1)
           Transcript 2 (2) Exon 2.7a      ---------------------------------------Exon 2.9c  PDB: B:69-249 (gaps) UniProt: 289-488 [INCOMPLETE]                                                                                                                             Transcript 2 (2)
                2gd4 B   16 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDAGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPK  249
                                    25        35        45        55      | 64        74        84        94       104       114      124A       131       141   ||  152       162       172       182   ||  190       200       210      |221  |    230       240         
                                                                        61A                                                           124A    131B|            145|                                   185A|                             217| 223A                          
                                                                                                                                               131A             147                                    185B                              219

Chain C from PDB  Type:PROTEIN  Length:418
 aligned with ANT3_HUMAN | P01008 from UniProtKB/Swiss-Prot  Length:464

    Alignment length:428
                                    45        55        65        75        85        95       105       115       125       135       145       155       165       175       185       195       205       215       225       235       245       255       265       275       285       295       305       315       325       335       345       355       365       375       385       395       405       415       425       435       445       455        
          ANT3_HUMAN     36 PVDICTAKPRDIPMNPMCIYRSPEKKATEDEGSEQKIPEATNRRVWELSKANSRFATTFYQHLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFFFAKLNCRLYRKANKSSKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAINKWVSNKTEGRITDVIPSEAINELTVLVLVNTIYFKGLWKSKFSPENTRKELFYKADGESCSASMMYQEGKFRYRRVAEGTQVLELPFKGDDITMVLILPKPEKSLAKVEKELTPEVLQEWLDELEEMMLVVHMPRFRIEDGFSLKEQLQDMGLVDLFSPEKSKLPGIVAEGRDDLYVSDAFHKAFLEVNEEGSEAAASTAVVIAGRSLNPNRVTFKANRPFLVFIREVPLNTIIFMGRVANPCV  463
               SCOP domains d2gd4c1 C:4-431 Antithr          ombin                                                                                                                                                                                                                                                                                                                                                                                                       SCOP domains
               CATH domains -----2gd4C01 C:9-224,C:          321-377 Antithrombin, subunit I, domain 2                                                                                                                                                   2gd4C02 C:225-320,C:383-430 Alpha-1-antitrypsin, domain 1                                       2gd4C01 C:9-224,C:321-377                                -----2gd4C02 C:225-320,C:383-430                     - CATH domains
               Pfam domains -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ..hhhhh................----------..........hhhhhhhhhhhhhhhhhhhhhhhh.....eeehhhhhhhhhhhhhh..hhhhhhhhhhh........hhhhhhhhhhhhhhhhhhhhhhhhheeee..eeeee.....hhhhhhhhhhhhh...eee....hhhhhhhhhhhhhhh....................eeeeeeeeee.......hhhhheeee.........eeeeeeeeeeeeeee.....eeeeee.....eeeeeee.....hhhhhhhh.hhhhhhhhhhh.eeeeeeeeee.eeeeeeeehhhhhhhh..hhhhhhhhh................eeeeeeeeee........................eeee....eeeeeee.....eeeeeee..... Sec.struct. author
             SAPs(SNPs) (1) ---N------------TF--C----------------L-----C---------CL----C--P-------------T--------K---D-R---F-K------------EAP-P-Y-----P-YQ-----T--P-------HL----------C-------C---------------F---ND---P-------------------I----G--T-----R---L-------K-------------I---------P--------P-------------N------P----------K----------------------------------------------P---------Q-----PH--R----------R-T-P--V----DCL-------C-TKGA-P-----------T--RT-D-LF- SAPs(SNPs) (1)
             SAPs(SNPs) (2) -------------------------------------------H---------------S-----------------------------------V------------------------------------------------------------------H---------------Y----K---------------------------------------------------------------V------------------------------------------------------------------------------------------------------------------------------------S--------H--------L---ML------------------------ SAPs(SNPs) (2)
             SAPs(SNPs) (3) -------------------------------------------S---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------P--------S----T------------------------ SAPs(SNPs) (3)
                PROSITE (2) --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------SERPIN     ------------------- PROSITE (2)
           Transcript 1 (1) Exon 1.3a  PDB: C:4-104 (gaps) UniProt: 14-136 [INCOMPLETE]                                          Exon 1.4c  PDB: C:105-176 UniProt: 137-208                              Exon 1.5a  PDB: C:177-222 UniProt: 209-254    Exon 1.6b  PDB: C:223-353 UniProt: 255-385                                                                                         ---------------------Exon 1.8a  PDB: C:375-431 UniProt: 407-464 [INCOMPLETE]   Transcript 1 (1)
           Transcript 1 (2) -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Exon 1.7a             --------------------------------------------------------- Transcript 1 (2)
                2gd4 C    4 PVDICTAKPRDIPMNPMCIYRSP----------EQKIPEATNRRVWELSKANSRFATTFYQHLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFFFAKLNCRLYRKANKASKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAINKWVSNKTEGRITDVIPSEAINELTVLVLVNTIYFKGLWKSKFSPENTRKELFYKADGESCSASMMYQEGKFRYRRVAEGTQVLELPFKGDDITMVLILPKPEKSLAKVEKELTPEVLQEWLDELEEMMLVVHMPRFRIEDGFSLKEQLQDMGLVDLFSPAASALPGIVAEGRDDLYVSDAFHKAFLEVNEEGSEAAASTAVVIAGRSLNPNRVTFKANRPFLVFIREVPLNTIIFMGRVANPCV  431
                                    13        23  |      -   |    43        53        63        73        83        93       103       113       123       133       143       153       163       173       183       193       203       213       223       233       243       253       263       273       283       293       303       313       323       333       343       353       363       373       383       393       403       413       423        
                                                 26         37

Chain H from PDB  Type:PROTEIN  Length:234
 aligned with FA10_HUMAN | P00742 from UniProtKB/Swiss-Prot  Length:488

    Alignment length:234
                                   244       254       264       274       284       294       304       314       324       334       344       354       364       374       384       394       404       414       424       434       444       454       464    
          FA10_HUMAN    235 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT  468
               SCOP domains d2gd4h1 H:16-244 Coagulation factor Xa, protease domain                                                                                                                                                                                    SCOP domains
               CATH domains 2gd4H01     2gd4H02 H:28-120,H:233-244 Trypsin-like serine proteases                                      2gd4H01 H:16-27,H:121-232 Trypsin-like serine proteases                                                             2gd4H02      CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ Pfam domains
         Sec.struct. author ..............eeeeee....eeeeee.....eeee..........eeeee............eee.eeeeee.............eeeee................hhhhhhhhh....eeeeee..............eeeeeeeehhhhhhhhh.........ee................eeeee....eeeeeee............eeeee...hhhhhhhhh.. Sec.struct. author
                 SAPs(SNPs) ---------------------------D--------------------------R--------------K-----------------N----W----------M-----------K-------M----S--C-------P-------AS------F-------------R-S-------------RD--------------------------N-------------------- SAPs(SNPs)
                PROSITE (1) TRYPSIN_DOM  PDB: H:16-243 UniProt: 235-467                                                                                                                                                                                              - PROSITE (1)
                PROSITE (2) -------------------------------------TRYPSI---------------------------------------------------------------------------------------------------------------------------------------TRYPSIN_SER -------------------------------------------- PROSITE (2)
           Transcript 2 (1) ---------------Exon 2.8e  PDB: H:31-69 UniProt: 250-289----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Transcript 2 (1)
           Transcript 2 (2) Exon 2.7a      ---------------------------------------Exon 2.9c  PDB: H:69-244 (gaps) UniProt: 289-488 [INCOMPLETE]                                                                                                                        Transcript 2 (2)
                2gd4 H   16 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDAGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKT  244
                                    25        35        45        55      | 64        74        84        94       104       114      124A       131       141   ||  152       162       172       182   ||  190       200       210      |221  |    230       240    
                                                                        61A                                                           124A    131B|            145|                                   185A|                             217| 223A                     
                                                                                                                                               131A             147                                    185B                              219

Chain I from PDB  Type:PROTEIN  Length:417
 aligned with ANT3_HUMAN | P01008 from UniProtKB/Swiss-Prot  Length:464

    Alignment length:427
                                    46        56        66        76        86        96       106       116       126       136       146       156       166       176       186       196       206       216       226       236       246       256       266       276       286       296       306       316       326       336       346       356       366       376       386       396       406       416       426       436       446       456       
          ANT3_HUMAN     37 VDICTAKPRDIPMNPMCIYRSPEKKATEDEGSEQKIPEATNRRVWELSKANSRFATTFYQHLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFFFAKLNCRLYRKANKSSKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAINKWVSNKTEGRITDVIPSEAINELTVLVLVNTIYFKGLWKSKFSPENTRKELFYKADGESCSASMMYQEGKFRYRRVAEGTQVLELPFKGDDITMVLILPKPEKSLAKVEKELTPEVLQEWLDELEEMMLVVHMPRFRIEDGFSLKEQLQDMGLVDLFSPEKSKLPGIVAEGRDDLYVSDAFHKAFLEVNEEGSEAAASTAVVIAGRSLNPNRVTFKANRPFLVFIREVPLNTIIFMGRVANPCV  463
               SCOP domains d2gd4i1 I:5-431 Antith          rombin                                                                                                                                                                                                                                                                                                                                                                                                      SCOP domains
               CATH domains ----2gd4I01 I:9-224,I:          321-377 Antithrombin, subunit I, domain 2                                                                                                                                                   2gd4I02 I:225-320,I:383-430 Alpha-1-antitrypsin, domain 1                                       2gd4I01 I:9-224,I:321-377                                -----2gd4I02 I:225-320,I:383-430                     - CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author .hhhhh................----------..........hhhhhhhhhhhhhhhhhhhhhhhh.....eeehhhhhhhhhhhhhh..hhhhhhhhhhh........hhhhhhhhhhhhhhhhhhhhhhhhheeee..eeeee.....hhhhhhhhhhhhh...eee....hhhhhhhhhhhhhhh....................eeeeeeeeee.......hhhhheeee.........eeeeeeeeeeeeeee.....eeeeee.....eeeeeee.....hhhhhhhh.hhhhhhhhhhh.eeeeeeeeee.eeeeeeeehhhhhhhh..hhhhhhhhh................eeeeeeeeee........................eeee....eeeeeee.....eeeeeee..... Sec.struct. author
             SAPs(SNPs) (1) --N------------TF--C----------------L-----C---------CL----C--P-------------T--------K---D-R---F-K------------EAP-P-Y-----P-YQ-----T--P-------HL----------C-------C---------------F---ND---P-------------------I----G--T-----R---L-------K-------------I---------P--------P-------------N------P----------K----------------------------------------------P---------Q-----PH--R----------R-T-P--V----DCL-------C-TKGA-P-----------T--RT-D-LF- SAPs(SNPs) (1)
             SAPs(SNPs) (2) ------------------------------------------H---------------S-----------------------------------V------------------------------------------------------------------H---------------Y----K---------------------------------------------------------------V------------------------------------------------------------------------------------------------------------------------------------S--------H--------L---ML------------------------ SAPs(SNPs) (2)
             SAPs(SNPs) (3) ------------------------------------------S---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------P--------S----T------------------------ SAPs(SNPs) (3)
                PROSITE (2) -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------SERPIN     ------------------- PROSITE (2)
           Transcript 1 (1) Exon 1.3a  PDB: I:5-104 (gaps) UniProt: 14-136 [INCOMPLETE]                                         Exon 1.4c  PDB: I:105-176 UniProt: 137-208                              Exon 1.5a  PDB: I:177-222 UniProt: 209-254    Exon 1.6b  PDB: I:223-353 UniProt: 255-385                                                                                         ---------------------Exon 1.8a  PDB: I:375-431 UniProt: 407-464 [INCOMPLETE]   Transcript 1 (1)
           Transcript 1 (2) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Exon 1.7a             --------------------------------------------------------- Transcript 1 (2)
                2gd4 I    5 VDICTAKPRDIPMNPMCIYRSP----------EQKIPEATNRRVWELSKANSRFATTFYQHLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFFFAKLNCRLYRKANKASKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAINKWVSNKTEGRITDVIPSEAINELTVLVLVNTIYFKGLWKSKFSPENTRKELFYKADGESCSASMMYQEGKFRYRRVAEGTQVLELPFKGDDITMVLILPKPEKSLAKVEKELTPEVLQEWLDELEEMMLVVHMPRFRIEDGFSLKEQLQDMGLVDLFSPAASALPGIVAEGRDDLYVSDAFHKAFLEVNEEGSEAAASTAVVIAGRSLNPNRVTFKANRPFLVFIREVPLNTIIFMGRVANPCV  431
                                    14        24 |       -  |     44        54        64        74        84        94       104       114       124       134       144       154       164       174       184       194       204       214       224       234       244       254       264       274       284       294       304       314       324       334       344       354       364       374       384       394       404       414       424       
                                                26         37

Chain L from PDB  Type:PROTEIN  Length:54
 aligned with FA10_HUMAN | P00742 from UniProtKB/Swiss-Prot  Length:488

    Alignment length:54
                                   135       145       155       165       175    
          FA10_HUMAN    126 RKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLER  179
               SCOP domains -d2gd4l1 L:87-138 Factor X, N-terminal module        - SCOP domains
               CATH domains 2gd4L00 L:86-139 Laminin                               CATH domains
               Pfam domains ------------------------------------------------------ Pfam domains
         Sec.struct. author .....hhhhhh..ee........ee....eee......eee............. Sec.struct. author
                 SAPs(SNPs) ----------------K------Y-YT--------------------------- SAPs(SNPs)
                PROSITE (1) -----------------------EGF_2           --------------- PROSITE (1)
                PROSITE (2) ------------------------------------------------------ PROSITE (2)
           Transcript 2 (1) Exon 2.6c  PDB: L:86-128 UniProt: 124-168  ----------- Transcript 2 (1)
           Transcript 2 (2) ------------------------------------------Exon 2.7a    Transcript 2 (2)
                2gd4 L   86 RKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLER  139
                                    95       105       115       125       135

Legend:		→ Mismatch	(orange background)
	-	→ Gap	(green background, '-', border residues have a numbering label)
		→ Modified Residue	(blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
	x	→ Chemical Group	(purple background, 'x', labelled with number + name, e.g. ACE or NH2)
	extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '\|'

Classification and Annotation

SCOP Domains (3, 6)

CATH Domains (4, 10)

Pfam Domains (0, 0)

Gene Ontology (34, 39)

Asymmetric Unit(hide GO term definitions)

Chain A,B,H,L (FA10_HUMAN | P00742)

molecular function
	GO:0005509	calcium ion binding	Interacting selectively and non-covalently with calcium ions (Ca2+).
	GO:0016787	hydrolase activity	Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.
	GO:0008233	peptidase activity	Catalysis of the hydrolysis of a peptide bond. A peptide bond is a covalent bond formed when the carbon atom from the carboxyl group of one amino acid shares electrons with the nitrogen atom from the amino group of a second amino acid.
	GO:0005543	phospholipid binding	Interacting selectively and non-covalently with phospholipids, a class of lipids containing phosphoric acid as a mono- or diester.
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0004252	serine-type endopeptidase activity	Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine).
	GO:0008236	serine-type peptidase activity	Catalysis of the hydrolysis of peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine).
biological process
	GO:0006888	ER to Golgi vesicle-mediated transport	The directed movement of substances from the endoplasmic reticulum (ER) to the Golgi, mediated by COP II vesicles. Small COP II coated vesicles form from the ER and then fuse directly with the cis-Golgi. Larger structures are transported along microtubules to the cis-Golgi.
	GO:0007596	blood coagulation	The sequential process in which the multiple coagulation factors of the blood interact, ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages: stage 1, the formation of intrinsic and extrinsic prothrombin converting principle; stage 2, the formation of thrombin; stage 3, the formation of stable fibrin polymers.
	GO:0007598	blood coagulation, extrinsic pathway	A protein activation cascade that contributes to blood coagulation and consists of the self-limited process linking exposure and activation of tissue factor to the activation of clotting factor X.
	GO:0007597	blood coagulation, intrinsic pathway	A protein activation cascade that contributes to blood coagulation and consists of the interactions among high molecular weight kininogen, prekallikrein, and factor XII that lead to the activation of clotting factor X.
	GO:0007599	hemostasis	The stopping of bleeding (loss of body fluid) or the arrest of the circulation to an organ or part.
	GO:0017187	peptidyl-glutamic acid carboxylation	The gamma-carboxylation of peptidyl-glutamic acid; catalyzed by the vitamin K dependent gamma-glutamyl carboxylase.
	GO:0030335	positive regulation of cell migration	Any process that activates or increases the frequency, rate or extent of cell migration.
	GO:0051897	positive regulation of protein kinase B signaling	Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
	GO:0006508	proteolysis	The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds.
	GO:0006465	signal peptide processing	The proteolytic removal of a signal peptide from a protein during or after transport to a specific location in the cell.
cellular component
	GO:0005796	Golgi lumen	The volume enclosed by the membranes of any cisterna or subcompartment of the Golgi apparatus, including the cis- and trans-Golgi networks.
	GO:0005788	endoplasmic reticulum lumen	The volume enclosed by the membranes of the endoplasmic reticulum.
	GO:0005576	extracellular region	The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
	GO:0031233	intrinsic component of external side of plasma membrane	The component of a plasma membrane consisting of gene products and protein complexes that penetrate the external side of the plasma membrane only, either directly or via some covalently attached hydrophobic anchor.
	GO:0005886	plasma membrane	The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

Chain C,I (ANT3_HUMAN | P01008)

molecular function
	GO:0008201	heparin binding	Interacting selectively and non-covalently with heparin, any member of a group of glycosaminoglycans found mainly as an intracellular component of mast cells and which consist predominantly of alternating alpha-(1->4)-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues.
	GO:0030414	peptidase inhibitor activity	Stops, prevents or reduces the activity of a peptidase, any enzyme that catalyzes the hydrolysis peptide bonds.
	GO:0002020	protease binding	Interacting selectively and non-covalently with any protease or peptidase.
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0004867	serine-type endopeptidase inhibitor activity	Stops, prevents or reduces the activity of serine-type endopeptidases, enzymes that catalyze the hydrolysis of nonterminal peptide bonds in a polypeptide chain; a serine residue (and a histidine residue) are at the active center of the enzyme.
biological process
	GO:0007596	blood coagulation	The sequential process in which the multiple coagulation factors of the blood interact, ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages: stage 1, the formation of intrinsic and extrinsic prothrombin converting principle; stage 2, the formation of thrombin; stage 3, the formation of stable fibrin polymers.
	GO:0007599	hemostasis	The stopping of bleeding (loss of body fluid) or the arrest of the circulation to an organ or part.
	GO:0010951	negative regulation of endopeptidase activity	Any process that decreases the frequency, rate or extent of endopeptidase activity, the endohydrolysis of peptide bonds within proteins.
	GO:0050728	negative regulation of inflammatory response	Any process that stops, prevents, or reduces the frequency, rate or extent of the inflammatory response.
	GO:0010466	negative regulation of peptidase activity	Any process that stops or reduces the rate of peptidase activity, the hydrolysis of peptide bonds within proteins.
	GO:2000266	regulation of blood coagulation, intrinsic pathway	Any process that modulates the frequency, rate or extent of blood coagulation, intrinsic pathway.
	GO:0007584	response to nutrient	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nutrient stimulus.
cellular component
	GO:0072562	blood microparticle	A phospholipid microvesicle that is derived from any of several cell types, such as platelets, blood cells, endothelial cells, or others, and contains membrane receptors as well as other proteins characteristic of the parental cell. Microparticles are heterogeneous in size, and are characterized as microvesicles free of nucleic acids.
	GO:0070062	extracellular exosome	A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
	GO:0005576	extracellular region	The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
	GO:0005615	extracellular space	That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
	GO:0005886	plasma membrane	The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

Description

Compounds

Structural Features

Chains, Units

Ligands, Modified Residues, Ions (5, 16)

Sites (16, 16)

SS Bonds (22, 22)

Cis Peptide Bonds (0, 0)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (109, 218)

PROSITE Motifs (5, 10)

Exons (10, 22)

Sequences/Alignments

Classification and Annotation

SCOP Domains (3, 6)

CATH Domains (4, 10)

Pfam Domains (0, 0)

Gene Ontology (34, 39)

Visualization

Interactive Views

Still Images

Databases and Analysis Tools

Databases

Analysis Tools

Related Entries

Entries Sharing at Least One Protein Chain (UniProt ID)

Related Entries Specified in the PDB File